Roche

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is a world leader in diagnostics, the leading supplier of medicines for cancer and transplantation and a market leader in virology. Roche employs roughly 70,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Additional information about the Roche Group is available on the Internet.

Genentech

Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, commercialize and manufacture biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions and over 50 projects in the pipeline. The company is the leading provider of anti-tumor therapeutics in the United States. With its strength in all areas of the drug development process - from research and development to manufacturing and commercialization - Genentech continues to transform innovative science into breakthrough therapies for patients.

Merck

Research Happens Around the World for People Around the World

Novel medicines that make a difference.

In August 2004, Merck Research Laboratories (MRL) opened its newest Laboratory and first new campus of the 21st Century in Boston, Massachusetts. The 300,000 square foot Boston research center features 26 labs with state-of-the-art equipment and a floor plan designed with innovation in mind. Immediately adjacent to the Longwood Medical and Academic Area, the new research facility is located in what is emerging as the latest hub of biomedical research in North America.

Research at MRL Boston applies scientific innovation to fuel drug development research, utilizing cutting-edge science for the discovery of novel medicines that are true advances in patient care with proven outcomes. MRL Boston and its close to 300 employees are dedicated to the discovery of therapeutics for Cancer and Neurodegenerative diseases such as Alzheimer's diseases.

The culture of the MRL Boston site embraces innovation and fosters multidisciplinary collaboration. Sharing data and ideas are central to project success. MRL Boston is organized to facilitate drug development efforts through improved process management and efficient interactions between its research teams. The opening of MRL Boston has created a rare opportunity for Merck scientists to work in an ideal research laboratory environment.

Ortho Biotech

Ortho Biotech Products, L.P. is a leading biopharmaceutical company that provides innovative products and services designed to help enhance the lives of individuals with serious chronic illnesses.

Following more than a decade of research and clinical practice, Ortho Biotech and its affiliates are recognized leaders in the treatment and research of anemia across multiple therapeutic areas. In addition to its scientific leadership, Ortho Biotech is at the forefront of developing innovative education and public policy initiatives that address unmet needs, and ensure that patients and their families, caregivers, advocates, and health care professionals have access to the latest treatment information, support services and quality care.

Formed in 1990, Ortho Biotech is part of a global organization, with U.S. headquarters in Bridgewater, New Jersey, and affiliates in Europe and Canada. Our commitment to developing and marketing innovative products, combined with our unparalleled dedication to patients, has become the hallmark of Ortho Biotech in the communities we serve.